Finance

Beta
Lists
NVRS:CNSX
Noveris Health Sciences Inc
CA$2.86
+4.00%
(+0.11) 1D
Jun 5, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NVRS...
Open
CA$2.85
High
CA$2.93
Low
CA$2.78
Mkt. cap
167.45M
Avg. vol.
93.41K
Volume
298.86K
P/E ratio
1.14
52-wk high
CA$3.00
52-wk low
CA$0.18
EPS
CA$2.51
No. of employees
3
Open
CA$2.85
High
CA$2.93
Low
CA$2.78
Mkt. cap
167.45M
Avg. vol.
93.41K
Volume
298.86K
P/E ratio
1.14
52-wk high
CA$3.00
52-wk low
CA$0.18
EPS
CA$2.51
No. of employees
3
News stories
From sources across the web
About Noveris Health Sciences Inc
CEO-
Employees3
Founded2013
HeadquartersVancouver, British Columbia, Canada
SectorPharmaceutical industry
Websitenoveris.health
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-40.14K
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
243.28K
-70.57K
5.04K
316.29K
Operating expense
243.28K
-110.70K
5.04K
316.29K
Total operating expenses
243.28K
-110.70K
5.04K
316.29K
Operating income
-243.28K
110.70K
-5.04K
-316.29K
Other non operating income
-28.66K
85.53K
-417.63K
-1.32M
EBT including unusual items
-12.95K
73.79K
3.16M
-1.62M
EBT excluding unusual items
-133.43K
73.79K
-405.27K
-1.62M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12.95K
73.79K
3.16M
-1.62M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-140.46K
-
-26.16K
-12.63K
Net interest expenses
-140.46K
-
-26.16K
-12.63K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer